Reduced starting dose of TKI is comparable to a full dose in metastatic kidney cancer
A study published in the Journal of Hematology Oncology Pharmacy [...]
A study published in the Journal of Hematology Oncology Pharmacy [...]
This study compared disease outcomes, treatments, and dose reductions in [...]
A recent post hoc analysis of the results from the [...]